ISRCTN03732556已完成未知
A Proof of Concept Randomised Controlled Trial to Examine the Potential Efficacy, Patient Acceptability and Feasibility of Cognitive-behavioural Therapy for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
South London and Maudsley NHS Foundation Trust (UK)0 个研究点目标入组 60 人开始时间: 2010年11月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
- 2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25207986 2. 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29282731
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 17/12/2012:
- •1. Men and women aged 18-65 with a diagnosis of adult ADHD according to NICE guidelines i.e. if there was evidence from both the participant and the informant (where available) that:
- •1.1. the participant met DSM-IV criteria for Adult ADHD both in childhood and adulthood
- •1.2. the participant experienced at least moderate psychological, social and/or educational or occupational impairment in multiple settings
- •1.3. symptoms occurred in two or more settings including social, familial, educational and/or occupational settings.
- •2. Participants will have received a diagnosis either from the Adult ADHD Service, Maudsley Hospital, London, UK or another specialist/secondary care service (in this case a copy of the diagnostic report will be required)
- •3. Participants will either already be attending follow-up clinics, including psychoeducation workshops, or will have been recently referred to the service for medication follow-up or psychological treatment
- •4. Currently score 6 or more on the inattentive or hyperactive/impulsive subscale of the Adult Barkley Current Behaviour Scale (self-rated)
- •5. Clinical severity of at least a moderate level (Clinical Global Impression score of 4 or above)
- •Previous inclusion criteria until 17/12/2012:
- •1. Men and women aged 18 to 65 who have received a diagnosis of adult ADHD in the Adult ADHD Service at the Maudsley Hospital, London, UK
- •2. Currently score 6 or more on the inattentive or hyperactive/impulsive subscale of the Adult Barkley Current Behaviour Scale (self-rated)
- •3. Clinical severity of at least a moderate level (Clinical Global Impression score of 4 or above)
- •4. If on medication to be on a stabilised dose as defined by no more than 10% change in medication dose over a two-month period
排除标准
- •1. Clinically significant anxiety disorder
- •2. Current episode major depression, current suicidality or self-harm (score of moderate or high suicidality on the M.I.N.I.)
- •3. Acquired brain injury
- •4. Primary diagnosis of psychosis or bipolar disorder
- •5. Pervasive developmental disorder
- •6. Active substance misuse/dependence in last three months
- •7. Verbal IQ <80
- •8. Diagnosis of a personality disorder
- •9. Participant not willing to comply with the requirements of an RCT
- •10. If the assessor does not perceive ADHD to be the current primary problem
研究者
相似试验
已完成
不适用
Weight loss Referrals for Adults in Primary care (WRAP)Overweight and ObesityNutritional, Metabolic, EndocrineObesityISRCTN82857232Medical Research Council (UK)1,267
已完成
不适用
Optimized TacrolimuS and MMF for HLA Antibodies after Renal TransplantatioTopic: Renal and UrogenitalSubtopic: Renal and Urogenital (all Subtopics)Disease: RenalInjury, Occupational Diseases, PoisoningKidney transplant failure and rejectionISRCTN46157828King's College London (UK)2,037
已完成
不适用
iQuit in practice: a study to examine a personalised web-and text message programme to support smoking cessation in Primary CareMental and Behavioural DisordersSmoking cessationMental and behavioural disorders due to use of tobaccoISRCTN56702353niversity of Cambridge (UK)600
已完成
2 期
The clinical effectiveness, safety and cost effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitisOphthalmologyEye DiseasesIridocyclitisISRCTN10065623niversity Hospitals Bristol NHS Foundation Trust (UK)90
已完成
不适用
Education programme (DESMOND-ID) for the self-management of type 2 diabetes for adults with intellectual disabilities (ID)Type 2 diabetesNutritional, Metabolic, EndocrineISRCTN93185560niversity of Ulster (UK)72